« Back
ESMO Immuno-Oncology Congress 2025
Dec 10 - Dec 12, 2025
The Immatics team will attend the ESMO Immuno-Oncology Congress 2025 in London.
Mini Oral Session
Date: December 11, 2025
Time: 12:05-12:10 PM
Room: Whittle Room
Abstract Number: 77MO
Title: A Phase 1 Trial of IMA203CD8, a PRAME-directed TCR T-cell Therapy in PRAME-positive Solid Tumors
Presenter: Prof. Dr. med. Antonia Busse, Charité, Berlin, Germany
For more information, visit the congress website by clicking here.
Location
London, UK